Buy L&T, target of Rs 1270: ULJK Securities

Published on Tue, Oct 14, 2008 at 18:10 |  Source : Moneycontrol.com

Updated at Tue, Oct 14, 2008 at 18:15  

116433 Investors following Larsen. Share this News with them.
0
0
Share on Tumblr

RELATED NEWS

ALSO READ

ULJK Securities has recommended a buy rating on Larsen and Toubro (L&T) with a target of Rs 1270 in its October 13, 2008 research report. "We measure the L&T standalone using the price earnings multiple methodology. On standalone basis we understand the company will grow its revenue at a CAGR of 30% by FY 2010E. The net profit of the company will grow to Rs 35,247 million in FY 2010E registering an EPS of Rs 60.23 for the year. The target price of Rs 1,270 per share encompasses a subsidiary valuation of Rs 186 per share. Further more, demerger of L&T Finance, L&T IDPL and L&T IT will unlock the value from the consolidated L&T, We assign buy rating to L&T," says ULJK Securities' research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click on the attachment......

Attachments : Larsen Toubro Ltd1.pdf

  

Trending News

Business News

Nokia PureLamda running WP 8.0 pops up on WP Bench app
Why the 'Old Boys' network stands up for Rajat Gupta "Why the 'Old Boys' network stands up for Rajat Gupta"

Vijay century powers CSK into IPL final

Arvind Saxena Says CNBC-TV18 Exclusive Expect 7-8% Growth For Hyundai In Calendar Year 2012

The latest earning numbers FIRST on CNBC-TV18
Videos

May 25 2012, 22:26

Expect single digit growth in ad revenue in FY13: Sun TV

- in Results Boardroom

May 25 2012, 22:26

NHPC posts profit amid capacity addition, delay woes

- in Results Boardroom

Interviews

May 25 2012, 22:00 | Source: CNBC-TV18

Petrol hike on soft global levels is short-sighted: Narayan  

May 25 2012, 15:54 | Source: CNBC-TV18

Capacity debottlenecking led to growth: Shasun Pharma  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!